Richard Sullivan

Editor-in-Chief, Journal of Cancer Policy (JCP), Director, Institute of Cancer Policy (ICP)

Richard Sullivan is Professor of Cancer and Global Health at King’s College London, and Director of the King’s Institute of Cancer Policy and co-Director of the Conflict and Health Research Group (kcl.ac.uk/research/conflict-health-research-group). 

His research interests extend from global cancer to conflict & health. Richard has worked on a number of Lancet and Lancet Oncology commissions, currently the Lancet Commission on Global Diagnostics (diagnosticscommission.org) and the Lancet Oncology European Cancer Research Commission. Richard’s research teams have major programs in capacity building in conflict and health, and humanitarian medicine, particularly in the Middle East and North Africa (r4hc-mena.org), as well as programmes in women’s health and cancer, digital innovation (virtual-reality enhanced surgery) and a wide range of global health security projects including on the COVID-19 pandemic and strengthening health systems in NW and NE Syria.  

His global cancer research programs cover cancer systems strengthening, affordability, value particularly and political economy, global radiotherapy, social welfare and cancer care in conflict.

Professor Sullivan qualified in medicine and trained in surgery (urology) gaining his PhD in Biochemistry from University College London. Richard was Clinical Director of Cancer Research UK between 1999 and 2008. He has also worked for many years on biosecurity and counterproliferation issues, including Ebola outbreaks in West Africa and DR Congo.  Richard is an NCD advisor to the WHO, a member of the National Cancer Grid of India and advisor (civil-military) to Save the Children.

Updated: May 2021